Physician profile
David Marc Herold
NPI 1306873724
$1,644.08
in general payments reported to CMS, 2019-2025
19 companies · $33.45 in 2025
The $33.45 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $494 · 2020: $64.57 · 2021: $130 · 2022: $284 · 2023: $224 · 2024: $414 · 2025: $33.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $671.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $322.71 | 2019-2024 | Dupixent |
| Novartis Pharmaceuticals Corporation | $241.33 | 2019-2025 | |
| Icad, INC | $195.96 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $146.47 | 2024 | Sotyktu |
| Abbvie INC. | $145.09 | 2022-2023 | |
| Janssen Scientific Affairs, LLC | $124.99 | 2019 | |
| Celgene Corporation | $84.70 | 2019 | |
| Incyte Corporation | $54.14 | 2022-2024 | Opzelura |
| Janssen Biotech, INC. | $48.91 | 2020-2022 | |
| Amgen INC. | $45.60 | 2019-2020 | |
| Ucb, INC. | $41.04 | 2023-2024 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $36.41 | 2019-2024 | |
| Leo Pharma INC. | $31.59 | 2022 | |
| Genzyme Corporation | $29.78 | 2024 | |
| Smith+Nephew, INC. | $27.56 | 2023 | Grafix Pl |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.80 | 2019 | |
| Mallinckrodt Hospital Products INC. | $19.88 | 2025 | Acthar |
| Organogenesis INC. | $13.12 | 2022 | |
| Glenmark Therapeutics INC. | $10.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Herold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.